These results thus suggested that the antitumor effect of Znf179 is through up-regulating differentiation of GBM-derived cells and reducing the tumor burden, but not through depleting the remaining cell population in the neural progenitor state or eradicating resistant cancer-initiating cells. Here, RNF112 is linked to neoplasm.